Neurovascular Embolization Devices Market Trends, Drivers, and Regional Analysis 2025–2029
Uncover key drivers, emerging technologies, and competitive movements shaping the neurovascular embolization devices market from 2025–2034 with trusted insights from The Business Research Company
How Is The Neurovascular Embolization Devices Market Size Expected To Expand Over 2029-2034?
The market for neurovascular embolization devices has shown steady expansion in recent years. It is forecast to increase from $1.32 billion in 2024 to $1.38 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.8%. This historical growth can be linked to the rising occurrence of neurovascular disorders, an increasing elderly population, the desire for minimally invasive operations, enhancements in healthcare infrastructure, and a boost in healthcare spending.
The neurovascular embolization devices market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors driving this growth during the forecast period include the increasing adoption of applications in developing markets, a focus on patient-focused care, heightened understanding of neurovascular conditions, innovations in imaging solutions, and greater financial commitments to research and development. Key trends anticipated over this period encompass customized treatment strategies, the incorporation of artificial intelligence into treatment formulation, the advent of advanced embolic substances, a move towards outpatient and ambulatory medical interventions, and the creation of novel embolization methods.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
Which Market Factors Are Fueling The Neurovascular Embolization Devices Industry Growth?
The growing occurrence of hemorrhages is expected to fuel the neurovascular embolization devices market in the coming years. Hemorrhages refer to abnormal, unchecked bleeding, which can occur internally within the body or externally through a breach in the skin or mucous membrane. The increased incidence of hemorrhages stems from multiple factors, such as an aging populace, a greater prevalence of hypertension, and the expanded utilization of anticoagulant medications. Neurovascular embolization devices are employed in instances of hemorrhagic strokes to obstruct anomalous blood vessels, thereby reducing bleeding and preventing additional harm to the brain. For instance, in February 2024, according to research conducted by King’s College London, a UK-based public research university, the volume of cases and deaths resulting from intracerebral hemorrhage (ICH) (a specific form of hemorrhage) is anticipated to rise by 59.4% in individuals aged 70 to 95 across the UK by 2050. Thus, the escalating prevalence of hemorrhages is a significant catalyst for the expansion of the neurovascular embolization devices market.
Which Categories Are Covered In The Neurovascular Embolization Devices Market Segmentation Analysis?
The neurovascular embolization devicesmarket covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
Which Market Trends Are Expected To Define The Future Of The Neurovascular Embolization Devices Market?
Major companies involved in neurovascular embolization devices are prioritizing the creation of products with advanced technology, including Shield Technology, to treat brain aneurysms and secure a market advantage. Shield Technology signifies an advanced feature designed to enhance the efficacy and safety of these devices, while also contributing to their overall durability and longevity. For example, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, launched the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter, in India. This device incorporates enhanced design features to improve its ease of use and reliability during endovascular procedures. It promotes cell growth in the inner lining of the blood vessel, offering a scaffold that aids in the minimally invasive treatment of aneurysms, reduces the risk of rupture, and enhances patient outcomes.
Which Organizations Are At The Forefront Of The Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co Ltd., MicroVention Inc., Balt USA LLC, Imperative Care Inc., InNeuroCo Inc., Acandis GmbH & Co KG, Rapid Medical Ltd., Emboline Inc., InspireMD Inc., QXMedical LLC, Vesalio LLC, EmbolX Inc
Download The Full Report Here:
Which Geographic Areas Are Driving Strong Demand For The Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp
Browse Through More Reports Similar to the Global Neurovascular Embolization Devices Market 2025, By The Business Research Company
Neuropathic Pain Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
Neurotrophic Keratitis Treatment Global Market Report 2025
Neurofibromatosis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
